Lymphoepithelioma-like carcinoma of breast-evaluation for Epstein-Barr virus-encoded RNA, human papillomavirus, and markers of basal cell differentiation.
This is a largest series of 5 cases of lymphoepithelioma-like carcinoma (LEC) of the breast attempting to look at the expression of basal cytokeratins (CKs), human papillomavirus, and Epstein-Barr virus-encoded RNAs in these tumors. Five cases were selected after stringent evaluation of all breast carcinomas showing dense lymphoid infiltration. Histologically, all these tumors showed the typical histology except 1 tumor that showed an unusual granulomatous response. All tumors were negative for estrogen and progesterone receptors and HER2 (triple negative). Three tumors expressed CK5/6 and high-molecular-weight CK, whereas only the case with nodal metastasis expressed CK14. Analysis for in situ hybridization for Epstein-Barr virus-encoded RNAs and human papillomavirus DNA on paraffin-processed tissues was negative in all tumors. All of these patients received adjuvant therapy. One patient with tumor expressing basal marker, CK5/6, had contralateral breast malignancy after a duration of 53 months of treatment completion. The rest were disease free with the follow-up period in the range of 6 to 105 months. The lymphoepithelioma-like carcinoma of breast expressed basal CK profile that is more CK5/6 positive than CK14. Analysis of basal markers within these tumors may help in refining the definition of these tumors and in classifying them into prognostically relevant groups.
Divisions of Surgical and Molecular Pathology, Department of Pathology, Tata Memorial Hospital (TMH) & Advanced Centre for Training, Research & Education in Cancer (ACTREC), Mumbai, India. Electronic address: tanujashet5@gmail.com.
Tanuja
T
Shet
Divisions of Surgical and Molecular Pathology, Department of Pathology, Tata Memorial Hospital (TMH) & Advanced Centre for Training, Research & Education in Cancer (ACTREC), Mumbai, India.
Trupti
T
Pai
Divisions of Surgical and Molecular Pathology, Department of Pathology, Tata Memorial Hospital (TMH) & Advanced Centre for Training, Research & Education in Cancer (ACTREC), Mumbai, India.
Omshree
O
Shetty
Divisions of Surgical and Molecular Pathology, Department of Pathology, Tata Memorial Hospital (TMH) & Advanced Centre for Training, Research & Education in Cancer (ACTREC), Mumbai, India.
Sangeeta
S
Desai
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000821:virology*; D002294:Carcinoma, Squamous Cell / Q000473:pathology* / Q000821:virology; D002454:Cell Differentiation / Q000502:physiology; D004279:DNA, Viral / Q000032:analysis*; D005260:Female; D004854:Herpesvirus 4, Human / Q000235:genetics*; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D017403:In Situ Hybridization / Q000379:methods; D008875:Middle Aged; D027383:Papillomaviridae / Q000302:isolation & purification*; D011379:Prognosis; D011980:Receptors, Progesterone / Q000235:genetics
D004279:DNA, Viral; D011980:Receptors, Progesterone
Basal cytokeratins; Breast; EBER-ISH; HPV; Lymphoepithelioma-like carcinoma